Treatment for Hepatitis C Virus Infection in Adults: Comparative Effectiveness
Background: Hepatitis C Virus Infection and Its Prevalence
Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the United States. HCV is primarily acquired by repeated percutaneous exposures to blood, with injection drug use being the strongest risk factor. Approximately 1.6 percent of U.S. adults over 20 years of age have antibodies to HCV, indicating prior acute HCV infection. About 70 to 85 percent of patients with acute HCV infection develop chronic HCV infection, defined by the presence of persistent viremia.
In the United States, about 75 percent of patients with HCV infection are infected with genotype 1, 20 percent are infected with genotype 2 or 3, and the remainder are infected with genotypes 4, 5, or 6 of the virus.
Chronic HCV infection is associated with an estimated 15,000 deaths each year in the United States. It is the most common indication for liver transplantation among American adults, accounting for more than 30 percent of cases. The prevalence of chronic HCV infection is thought to have peaked in 2001 at 3.6 million people, and the yearly incidence has declined from more than 200,000 cases per year in the 1980s to around 16,000 cases in 2009.
- Chou R, Hartung D, Rahman B, et al. Treatment for Hepatitis C Virus Infection in Adults: A Comparative Effectiveness Review. Evidence Report No. 76 (Prepared by the Oregon Evidence-based Practice Center under Contract No. 290-2007-10057-I). Rockville, MD: Agency for Healthcare Research and Quality; August 2012. AHRQ Publication No. 12-EHC113-EF. Available at www.effectivehealthcare.ahrq.gov/hepctreatment.cfm.
- Centers for Disease Control and Prevention. Hepatitis C Information for Health Professionals. Updated March 14, 2011. Available at www.cdc.gov/hepatitis/HCV.
- Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144(10):705-14. PMID: 16702586.
- Davis GL, Alter MJ, El-Serag H, et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010;138(2):513-21. PMID: 19861128.
- Ly KN, Xing J, Klevens RM, et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156(4):271-8. PMID: 22351712.
- Nainan OV, Alter MJ, Kruszon-Moran D, et al. Hepatitis C virus genotypes and viral concentration in participants of a general population survey in the United States. Gastroenterology 2006;131(2):478-84. PMID: 16890602.
Your slide tray is being processed.